Acadia Healthcare Company, Inc. Stock price

Equities

ACHC

US00404A1097

Healthcare Facilities & Services

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
79.22 USD +1.12% Intraday chart for Acadia Healthcare Company, Inc. +4.87% +1.88%
Sales 2024 * 3.22B Sales 2025 * 3.54B Capitalization 7.31B
Net income 2024 * 328M Net income 2025 * 372M EV / Sales 2024 * 2.79 x
Net Debt 2024 * 1.68B Net Debt 2025 * 1.65B EV / Sales 2025 * 2.53 x
P/E ratio 2024 *
22.4 x
P/E ratio 2025 *
20 x
Employees 20,250
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.2%
More Fundamentals * Assessed data
Dynamic Chart
Acadia Healthcare Completes 3 Comprehensive Treatment Centers Acquisition MT
Acadia Healthcare Company, Inc. acquired Comprehensive Treatment Center in Greenville, North Carolina. CI
Acadia Healthcare Company, Inc. acquired Comprehensive Treatment Center in Raleigh, North Carolina. CI
Tufts Medicine and Acadia Healthcare Company Break Ground on New Behavioral Health Hospital to Serve Greater Boston Area CI
Transcript : Acadia Healthcare Company, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 10:45 AM
Mizuho Securities Price Target on Acadia Healthcare to $84 From $77, Maintains Neutral Rating MT
Acadia Healthcare Company Seeks M&A CI
Transcript : Acadia Healthcare Company, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 10:25 AM
TD Cowen Adjusts Price Target on Acadia Healthcare to $101 From $86, Maintains Outperform Rating MT
Deutsche Bank Raises Acadia Healthcare Price Target to $70 From $68, Maintains Sell Rating MT
UBS Raises Acadia Healthcare Price Target to $102 From $88, Maintains Buy Rating MT
Acadia Healthcare Seeks Acquisitions CI
Transcript : Acadia Healthcare Company, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Acadia Healthcare Q4 Adjusted Earnings, Revenue Rise; Sets Guidance MT
Acadia Healthcare Company, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024 CI
More news
1 day+1.12%
1 week+4.87%
Current month-5.07%
1 month-5.05%
3 months+1.24%
6 months+12.61%
Current year+1.88%
More quotes
1 week
76.06
Extreme 76.06
80.03
1 month
75.00
Extreme 75
86.56
Current year
75.00
Extreme 75
87.77
1 year
66.49
Extreme 66.49
87.77
3 years
50.07
Extreme 50.07
89.85
5 years
11.09
Extreme 11.09
89.85
10 years
11.09
Extreme 11.09
89.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 22-04-10
Director of Finance/CFO 51 23-07-09
Chief Tech/Sci/R&D Officer - 22-01-02
Members of the board TitleAgeSince
Director/Board Member 70 11-03-31
Director/Board Member 59 12-01-18
Director/Board Member 68 18-12-15
More insiders
Date Price Change Volume
24-03-28 79.22 +1.12% 777,102
24-03-27 78.34 +2.01% 490,904
24-03-26 76.8 +0.72% 617,316
24-03-25 76.25 -0.31% 424,963
24-03-22 76.49 +1.26% 582,488

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States. The Company's facilities and services are classified into various categories, such as acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs) and residential treatment centers. Outpatient programs associated with its facilities are included within each respective service line. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. It operates a network of over 253 behavioral healthcare facilities with 11,200 beds in 38 states and Puerto Rico.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
79.22 USD
Average target price
95.58 USD
Spread / Average Target
+20.66%
Consensus
  1. Stock
  2. Equities
  3. Stock Acadia Healthcare Company, Inc. - Nasdaq